NCT01910428 - L-asparaginase Encapsulated in Red Blood Cells (Eryaspase) for Treatment of Adult Patients With ALL or LBL | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 25, 2018

Study Completion Date

March 31, 2018

Conditions

Acute Lymphoblastic LeukemiaLymphoblastic Lymphoma

Interventions

DRUG

L-asparaginase encapsulated in RBC

"* 50 IU/kg IV~* 100 IU/kg IV~* 150 IU/kg IV~* 200 IU/kg IV"

Trial Locations (5)

Monter Cancer Center, Lake Success

University of Maryland, Greenebaum Comprehensive Cancer Center, Baltimore

Duke University, Durham

Ohio State University, Columbus

University of Chicago, Chicago